Literature DB >> 11245857

Inhibition by nifedipine of adherence- and activated macrophage-induced death of human gingival fibroblasts.

Y Fujimori1, S Maeda, M Saeki, I Morisaki, Y Kamisaki.   

Abstract

The effects of nifedipine on the death and proliferation of gingival fibroblasts were investigated to elucidate the mechanism of gingival overgrowth that is associated with chronic administration of Ca2+ channel blockers. The number of adhered viable and dead fibroblasts obtained from healthy human gingiva increased after confluence, whereas cell death was inhibited by nifedipine in a concentration-dependent manner. A similar inhibition was also observed in the presence of other calcium channel blockers, such as nicardipine, diltiazem, and verapamil. When gingival fibroblasts were co-cultured with RAW264 (macrophage-like) cells, lipopolysaccharide (LPS) caused the concentration-dependent death of fibroblasts. Nifedipine significantly inhibited the LPS-induced cell death. Although neither LPS nor N-ethyl-2-(1-ethyl-2-hydroxy-2-nitroso-hydrazino)-ethanamine, a nitric oxide donor, directly caused fibroblast death, 3-morpholino-sydnonimine (SIN-1), a peroxynitrite donor, induced fibroblast death, regardless of the presence of RAW cells. The cell death induced by SIN-1 was not affected by nifedipine treatment. LPS stimulation caused an increase in the immunoreactivity of inducible nitric oxide synthase (iNOS) and in the nitrite concentration in the incubation medium of RAW cells. The induction of iNOS was completely prevented by the incubation with nifedipine. The inhibition by nifedipine of nitrite production in RAW cells was also observed after treatment with nicardipine, but not with either diltiazem or verapamil. Therefore, the inhibition by nifedipine of both adherence- and LPS-stimulated macrophage-induced death of fibroblasts may be the mechanism of gingival overgrowth seen during chronic treatment with Ca(2+) channel blockers.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11245857     DOI: 10.1016/s0014-2999(01)00810-x

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

1.  Nitric oxide at a low concentration protects murine macrophage RAW264 cells against nitric oxide-induced death via cGMP signaling pathway.

Authors:  Y Yoshioka; A Yamamuro; S Maeda
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

2.  Immunotherapy of cerebrovascular amyloidosis in a transgenic mouse model.

Authors:  Veronica Lifshitz; Ronen Weiss; Tali Benromano; Einat Kfir; Tamar Blumenfeld-Katzir; Catherine Tempel-Brami; Yaniv Assaf; Weiming Xia; Tony Wyss-Coray; Howard L Weiner; Dan Frenkel
Journal:  Neurobiol Aging       Date:  2011-03-02       Impact factor: 4.673

3.  Nifedipine and phenytoin induce matrix synthesis, but not proliferation, in intact human gingival connective tissue ex vivo.

Authors:  Shawna S Kim; Sarah Michelsons; Kendal Creber; Michael J Rieder; Douglas W Hamilton
Journal:  J Cell Commun Signal       Date:  2015-08-23       Impact factor: 5.782

Review 4.  Drugs, medications and periodontal disease.

Authors:  P A Heasman; F J Hughes
Journal:  Br Dent J       Date:  2014-10       Impact factor: 1.626

Review 5.  Molecular and clinical aspects of drug-induced gingival overgrowth.

Authors:  P C Trackman; A Kantarci
Journal:  J Dent Res       Date:  2015-02-13       Impact factor: 6.116

6.  The role of inflammation and apoptosis in cyclosporine A-induced gingival overgrowth.

Authors:  Kristina Mitic; Mirjana Popovska; Maja Pandilova; Rubens Jovanovic; Goce Spasovski; Vladimir Nikolov
Journal:  Bosn J Basic Med Sci       Date:  2013-02       Impact factor: 3.363

Review 7.  Pathologic crossroads: cardio-vascular diseases, periodontal diseases and calcium antagonists.

Authors:  H Balan; E Popescu; G Angelescu
Journal:  J Med Life       Date:  2011-02-25

8.  On the Cellular and Molecular Mechanisms of Drug-Induced Gingival Overgrowth.

Authors:  Albert Ramírez-Rámiz; Lluís Brunet-LLobet; Eduard Lahor-Soler; Jaume Miranda-Rius
Journal:  Open Dent J       Date:  2017-07-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.